AI30904/AI/NIAID NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1993	2
1994	1
1995	1
1997	3
1998	2
1999	1
2000	1
2001	3
2002	2
2004	1
2005	1
2011	1
2012	1
2013	2
2014	1
2015	1
2021	0

1

Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccine.

Abbott JR, Sanou MP, Coleman JK, Yamamoto JK. Abbott JR, et al. Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):246-54. doi: 10.1016/j.vetimm.2011.06.019. Epub 2011 Jun 12. Vet Immunol Immunopathol. 2011. PMID: 21719117 Free PMC article. Review.

2

Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.

Pu R, Coleman J, Coisman J, Sato E, Tanabe T, Arai M, Yamamoto JK. Pu R, et al. J Feline Med Surg. 2005 Feb;7(1):65-70. doi: 10.1016/j.jfms.2004.08.005. J Feline Med Surg. 2005. PMID: 15686976 Review.

3

Utilization of feline ELISPOT for mapping vaccine epitopes.

Abbott JR, Pu R, Coleman JK, Yamamoto JK. Abbott JR, et al. Methods Mol Biol. 2012;792:47-63. doi: 10.1007/978-1-61779-325-7_4. Methods Mol Biol. 2012. PMID: 21956500

4

FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review.

Uhl EW, Heaton-Jones TG, Pu R, Yamamoto JK. Uhl EW, et al. Vet Immunol Immunopathol. 2002 Dec;90(3-4):113-32. doi: 10.1016/s0165-2427(02)00227-1. Vet Immunol Immunopathol. 2002. PMID: 12459160 Free PMC article. Review.

5

Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.

Coleman JK, Pu R, Martin MM, Noon-Song EN, Zwijnenberg R, Yamamoto JK. Coleman JK, et al. Vaccine. 2014 Feb 3;32(6):746-54. doi: 10.1016/j.vaccine.2013.05.024. Epub 2013 Jun 22. Vaccine. 2014. PMID: 23800540 Free PMC article.

6

Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.

Roff SR, Sanou MP, Rathore MH, Levy JA, Yamamoto JK. Roff SR, et al. Hum Vaccin Immunother. 2015;11(6):1540-56. doi: 10.1080/21645515.2015.1026500. Hum Vaccin Immunother. 2015. PMID: 25844718 Free PMC article.

7

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

Arai M, Earl DD, Yamamoto JK. Arai M, et al. Vet Immunol Immunopathol. 2002 Mar;85(3-4):189-204. doi: 10.1016/s0165-2427(01)00426-3. Vet Immunol Immunopathol. 2002. PMID: 11943320

8

Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects.

Sanou MP, Roff SR, Mennella A, Sleasman JW, Rathore MH, Yamamoto JK, Levy JA. Sanou MP, et al. J Virol. 2013 Sep;87(18):10004-15. doi: 10.1128/JVI.00359-13. Epub 2013 Jul 3. J Virol. 2013. PMID: 23824804 Free PMC article.

9

Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.

Omori M, Pu R, Tanabe T, Hou W, Coleman JK, Arai M, Yamamoto JK. Omori M, et al. Vaccine. 2004 Dec 2;23(3):386-98. doi: 10.1016/j.vaccine.2004.05.032. Vaccine. 2004. PMID: 15530685

10

Feline bone marrow transplantation: its use in FIV-infected cats.

Yamamoto JK, Pu R, Arai M, Pollock D, Irausquin R, Bova FJ, Fox LE, Homer BL, Gengozian N. Yamamoto JK, et al. Vet Immunol Immunopathol. 1998 Oct 23;65(2-4):323-51. doi: 10.1016/s0165-2427(98)00165-2. Vet Immunol Immunopathol. 1998. PMID: 9839883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results